Breast Carcinoma In Situ Clinical Trials

ReadTheTrial indexes 1 studies for Breast Carcinoma In Situ. The most common development stage is Phase 3 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

1 clinical trials found for Breast Carcinoma In Situ.

Pipeline by Phase

PhaseTrialsDistribution
Phase 3 1
100%

Trial Status Breakdown

Trials for Breast Carcinoma In Situ

A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy

NCT02954874 · ACTIVE NOT RECRUITING · Phase 3

Frequently Asked Questions

What clinical trials are available for Breast Carcinoma In Situ?

There are 1 clinical trials listed for Breast Carcinoma In Situ. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Breast Carcinoma In Situ trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Breast Carcinoma In Situ trials in?

Current Breast Carcinoma In Situ trials are distributed across: Phase 3 (1).

Find More Trials